US 8765813
Use of treprostinil to treat and prevent ischemic lesions
granted A61KA61K31/191A61K31/201
Quick answer
US patent 8765813 (Use of treprostinil to treat and prevent ischemic lesions) held by United Therapeutics Corporation expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K31/191, A61K31/201, A61K31/557, A61P